GlassScriptPhysician profile
Tara J Smith
NPI 1497263008
$306.47
in general payments reported to CMS, 2019-2025
10 companies · $78.28 in 2025
The $78.28 reported for 2025 was less than what a typical Psychiatric/Mental Health (Nurse Practitioner) provider received nationally (typical 2025 total: $257).
See the full distribution for Psychiatric/Mental Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $60.59 · 2023: $125 · 2024: $42.21 · 2025: $78.28.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $246.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $245.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $65.23 | 2023-2024 | |
| Janssen Pharmaceuticals, INC | $49.17 | 2021-2023 | Spravato |
| Corium, LLC | $48.09 | 2023-2025 | Azstarys |
| Vanda Pharmaceuticals INC. | $25.18 | 2025 | Fanapt |
| Novo Nordisk INC | $23.09 | 2021 | |
| Alkermes, INC. | $22.00 | 2025 | Aristada, Lybalvi |
| Solventum Corporation | $21.73 | 2025 | Prevena, V.A.C. Granufoam |
| Supernus Pharmaceuticals, INC. | $18.16 | 2023 | Qelbree |
| Otsuka America Pharmaceutical, INC. | $17.25 | 2021 | |
| Almatica Pharma LLC | $16.57 | 2024 | Loreev Xr |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tara Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.